Clinical Trial Update: Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer [NA]

View source ↗

Summary

The study evaluated radiofrequency ablation as a treatment for Stage I non-small cell lung cancer, and results from the completed trial have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Lung Cancer | NA | Status: COMPLETED | Results posted: 2017-01-24